GENE ONLINE|News &
Opinion
Blog

2026-04-09|

State Street Expands Partnership with Thornburg to Support New ETF Share Classes

by GOAI
Share To

State Street Corporation has announced an expansion of its longstanding partnership with Thornburg Investment Management to provide services for Thornburg’s newly launched exchange-traded fund (ETF) share classes. The collaboration will focus on supporting the operational needs of these new ETF offerings, which represent a significant development in Thornburg’s investment product lineup.

Thornburg introduced ETF share classes as part of its mutual funds, marking a strategic move to offer investors greater flexibility and accessibility. State Street will deliver a range of services to support this initiative, including custody, accounting, and administrative solutions tailored specifically for ETFs. This builds upon the existing relationship between the two firms, which spans several years and includes various asset servicing arrangements. Both companies aim to leverage their combined expertise to ensure seamless operations for these innovative investment products.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 9, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top